CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome

Steroids

Volumn 76, Issue 12, 2011, Pages 1383-1388

  Lecke, Sheila B ^a   Morsch, Débora M ^a   Spritzer, Poli M ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aromatase; Hypertension; PCOS; Subcutaneous adipose tissue

Indexed keywords

ANDROGEN; AROMATASE; ESTRADIOL; ESTROGEN; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ARTICLE; BIOPSY; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; HYPERTENSION; LUTEINIZING HORMONE BLOOD LEVEL; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; SUBCUTANEOUS FAT; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANDROGENS; AROMATASE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; GENE EXPRESSION; HUMANS; HYPERINSULINISM; HYPERTENSION; INSULIN; POLYCYSTIC OVARY SYNDROME; SUBCUTANEOUS FAT;

EID: 80052751492     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.07.008     Document Type: Article

References (52)

1. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749 (Pubitemid 38766360)
2. D.A. Ehrmann Polycystic ovary syndrome N Engl J Med 352 2005 1223 1236
3. R. Azziz, L.A. Sanchez, E.S. Knochenhauer, C. Moran, J. Lazenby, and K.C. Stephens Androgen excess in women: experience with over 1000 consecutive patients J Clin Endocrinol Metab 89 2004 453 462 (Pubitemid 38269843)
4. D.A. Ehrmann, D.R. Liljenquist, K. Kasza, R. Azziz, R.S. Legro, and M.N. Ghazzi Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 48 53 (Pubitemid 43069116)
5. T. Sathyapalan, and S.L. Atkin Mediators of inflammation in polycystic ovary syndrome in relation to adiposity Mediators Inflamm 2010 2010 758656
6. D. Wiltgen, and P.M. Spritzer Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes Fertil Steril 94 2010 2493 2496
7. T. Apridonidze, P.A. Essah, M.J. Iuorno, and J.E. Nestler Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome J Clin Endocrinol Metab 90 2005 1929 1935 (Pubitemid 40586223)
8. P.M. Spritzer, and D. Wiltgen Prevalence of metabolic syndrome in patients of south of Brazil with polycystic ovary syndrome (PCOS) Arq Bras Endocrinol Metabol 51 2007 146 147
9. B.O. Yildiz, K.S. Woods, F. Stanczyk, A. Bartolucci, and R. Azziz Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 5558 5562 (Pubitemid 39518440)
10. D.S. Guzick Do cardiovascular risk factors in polycystic ovarian syndrome result in more cardiovascular events? J Clin Endocrinol Metab 93 2008 1170 1171 (Pubitemid 351519703)
11. V.P. Jovanovic, E. Carmina, and R.A. Lobo Not all women diagnosed with PCOS share the same cardiovascular risk profiles Fertil Steril 94 2010 826 832
12. M. Rizzo, K. Berneis, G. Spinas, G.B. Rini, and E. Carmina Long-term consequences of polycystic ovary syndrome on cardiovascular risk Fertil Steril 91 2009 1563 1567
13. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, and W. Futterweit Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2010 2038 2049
14. K. Blouin, M. Nadeau, J. Mailloux, M. Daris, S. Lebel, and V. Luu-The Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis Am J Physiol Endocrinol Metab 296 2009 E244 E255
15. F.M. Gregoire Adipocyte differentiation: from fibroblast to endocrine cell Exp Biol Med (Maywood) 226 2001 997 1002
16. E.R. Simpson, C. Clyne, G. Rubin, W.C. Boon, K. Robertson, and K. Britt Aromatase - a brief overview Annu Rev Physiol 64 2002 93 127 (Pubitemid 34259227)
17. A. Belgorosky, G. Guercio, C. Pepe, N. Saraco, and M.A. Rivarola Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence Horm Res 72 2009 321 330
18. R.J. Santen, H. Brodie, E.R. Simpson, P.K. Siiteri, and A. Brodie History of aromatase: saga of an important biological mediator and therapeutic target Endocr Rev 30 2009 343 375
19. I. Peter, A.M. Shearman, D.R. Zucker, C.H. Schmid, S. Demissie, and L.A. Cupples Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study J Hypertens 23 2005 2193 2200 (Pubitemid 41666749)
20. R. Ramirez-Lorca, A. Grilo, M.T. Martinez-Larrad, L. Manzano, F.J. Serrano-Hernando, and F.J. Moron Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants Hypertension 50 2007 884 890 (Pubitemid 350287530)
21. M. Shimodaira, T. Nakayama, N. Sato, K. Saito, A. Morita, and I. Sato Association study of aromatase gene (CYP19A1) in essential hypertension Int J Med Sci 5 2008 29 35 (Pubitemid 351270279)
22. Y. Yagil, and C. Yagil Estrogen-related genes and blood pressure: an example of the complexity of advanced association studies J Hypertens 23 2005 2147 2149 (Pubitemid 41666742)
23. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
24. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, and W. Futterweit The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 2009 456 488
25. A.P. Nacul, C.D. Andrade, P. Schwarz, P.I. de Bittencourt Jr. , and P.M. Spritzer Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity Eur J Obstet Gynecol Reprod Biol 133 2007 191 196 (Pubitemid 47069681)
26. P.M. Spritzer, K.O. Lisboa, S. Mattiello, and F. Lhullier Spironolactone as a single agent for long-term therapy of hirsute patients Clin Endocrinol (Oxf) 52 2000 587 594 (Pubitemid 30337084)
27. P.M. Spritzer, M. Poy, D. Wiltgen, L.S. Mylius, and E. Capp Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements Hum Reprod 16 2001 1340 1346 (Pubitemid 32640305)
28. M. Toscani, R. Migliavacca, J.A. Sisson de Castro, and P.M. Spritzer Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome Metabolism 56 2007 992 997 (Pubitemid 46890983)
29. D. Wiltgen, I.G. Benedetto, L.S. Mastella, and P.M. Spritzer Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome Hum Reprod 24 2009 1726 1731
30. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
31. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
32. G.B. Donato, S.C. Fuchs, K. Oppermann, C. Bastos, and P.M. Spritzer Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio Menopause 13 2006 280 285
33. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
34. D.M. Morsch, M.M. Carneiro, S.B. Lecke, F.C. Araujo, A.F. Camargos, and F.M. Reis C-fos gene and protein expression in pelvic endometriosis: a local marker of estrogen action J Mol Histol 40 2009 53 58
35. I.O. Oliveira, C. Lhullier, I.S. Brum, and P.M. Spritzer Gene expression of type 2 17 beta hydroxysteroid dehydrogenase in scalp hairs of hirsute women Steroids 68 2003 641 649 (Pubitemid 37075925)
36. R. Higuchi, G. Dollinger, P.S. Walsh, and R. Griffith Simultaneous amplification and detection of specific DNA sequences Biotechnology (NY) 10 1992 413 417
37. R. Higuchi, C. Fockler, G. Dollinger, and R. Watson Kinetic PCR analysis: real-time monitoring of DNA amplification reactions Biotechnology (NY) 11 1993 1026 1030 (Pubitemid 23254023)
38. H. Zipper, H. Brunner, J. Bernhagen, and F. Vitzthum Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications Nucleic Acids Res 32 2004 e103
39. Applied Biosystems. Relative quantitation of gene expression experimental design and analysis: relative standard curve method and comparative Ct method (ΔΔCt). Guide to performing relative quantitation of gene expression using real-time quantitative PCR. Foster City: Apllied Byosystems; 2004. p. 34-49.
40. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408 (Pubitemid 34164012)
41. I. Saito Insulin resistance and hypertension in adolescents and adults Intern Med 41 2002 64 66 (Pubitemid 34196219)
42. L.J. Shaw, C.N. Bairey Merz, R. Azziz, F.Z. Stanczyk, G. Sopko, and G.D. Braunstein Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation J Clin Endocrinol Metab 93 2008 1276 1284 (Pubitemid 351519721)
43. J. Sierra-Johnson, B.D. Johnson, T.G. Allison, K.R. Bailey, G.L. Schwartz, and S.T. Turner Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance Diabetes Care 29 2006 668 672 (Pubitemid 44115371)
44. I. Czajka-Oraniec, and E.R. Simpson Aromatase research and its clinical significance Endokrynol Pol 61 2010 126 134
45. N. Harada, H. Sasano, H. Murakami, T. Ohkuma, H. Nagura, and Y. Takagi Localized expression of aromatase in human vascular tissues Circ Res 84 1999 1285 1291 (Pubitemid 29270043)
46. E.R. Simpson Sources of estrogen and their importance J Steroid Biochem Mol Biol 86 2003 225 230 (Pubitemid 37412561)
47. B. Antuna-Puente, B. Feve, S. Fellahi, and J.P. Bastard Adipokines: the missing link between insulin resistance and obesity Diabetes Metab 34 2008 2 11
48. D.I. Spratt, J.R. Morton, R.S. Kramer, S.W. Mayo, C. Longcope, and C.P. Vary Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization Am J Physiol Endocrinol Metab 291 2006 E631 E638 (Pubitemid 44352271)
49. S.E. Bulun, D. Chen, M. Lu, H. Zhao, Y. Cheng, and M. Demura Aromatase excess in cancers of breast, endometrium and ovary J Steroid Biochem Mol Biol 106 2007 81 96 (Pubitemid 47362640)
50. A. Maccio, C. Madeddu, and G. Mantovani Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives Obes Rev 10 2009 660 670
51. I. Peter, A. Kelley-Hedgepeth, G.S. Huggins, D.E. Housman, M.E. Mendelsohn, and J.A. Vita Association between arterial stiffness and variations in oestrogen-related genes J Hum Hypertens 23 2009 636 644
52. R.S. Legro, W.D. Schlaff, M.P. Diamond, C. Coutifaris, P.R. Casson, and R.G. Brzyski Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism J Clin Endocrinol Metab 95 2010 5305 5313